USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
12 Jan 2022 | 03:45 PM GMT

Best routes to market for Remote Patient Monitoring companies

Anchored by:

Alexander Klein
Founder & CEO
NEDICARE
Dr. Nick (Nemanja) Kovacev
Head of Healthcare and Life Sciences Practice
HTEC GROUP

Participants:

Alexander Klein Founder & CEONedicare
Alexander Klein
Founder & CEONedicare
Dr. Nick (Nemanja) Kovacev Head of Healthcare and Life Sciences PracticeHTEC Group
Dr. Nick (Nemanja) Kovacev
Head of Healthcare and Life Sciences PracticeHTEC Group
Meaghan Schedel Senior Digital Health ConsultantHealthXL
Meaghan Schedel
Senior Digital Health ConsultantHealthXL
Aahuti Rai NED, Advisor & Venture PartnerFour Points Health | Conduit Connect
Aahuti Rai
NED, Advisor & Venture PartnerFour Points Health | Conduit Connect
Abhishek Shah Co-Founder & CEOWellthy Therapeutics Pvt. Ltd.
Abhishek Shah
Co-Founder & CEOWellthy Therapeutics Pvt. Ltd.
Malin Johansson Vice PresidentNovo Nordisk
Malin Johansson
Vice PresidentNovo Nordisk
Mark Grossman VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works
Mark Grossman
VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works
Piotr Sokolowski Chief Medtech StrategistS3 Connected Health
Piotr Sokolowski
Chief Medtech StrategistS3 Connected Health
Richie Bavasso PresidentPneumoWave
Richie Bavasso
PresidentPneumoWave
Vasyl Pyrozhyk Vice PresidentSMBC
Vasyl Pyrozhyk
Vice PresidentSMBC
Vasyl Pyrozhyk Vice President - HealthcareSumitomo Mitsui Banking Corporation
Vasyl Pyrozhyk
Vice President - HealthcareSumitomo Mitsui Banking Corporation
Zina Manji Founder/Principal, Regulatory StrategistInnopathwayz, LLC
Zina Manji
Founder/Principal, Regulatory StrategistInnopathwayz, LLC

About this Meeting

Are you working on Remote Patient Monitoring programs (RPM)? Do you struggle in scaling them in a sustainable way? This meeting is your opportunity to have a peer to peer conversation with other senior leaders on the best routes to market for RPM programs. More specifically, we will discuss the following:

  •  What are the most scalable and sustainable commercialization models for RPM (e.g partnerships with payers, employers, pharma, medtech, hospitals, D2C, etc)? Is there an opportunity for RPM companies to build partnerships with other digital health companies?
  •  Key considerations to ensure a successful commercialisation model - Challenges & Requirements of the different stakeholders (e.g. interoperability, reimbursement, evidence, regulation, engagement, etc)
  •  Factors that determine the best route to market (e.g geographies, demographic group, disease, objective of the program, others)